Hey bluebrando, Yep the results on Friday were what we would...

Hey bluebrando,
Yep the results on Friday were what we would have dreamt for. But as a business model moving forward, IMU next needs to show either revenue or a partnership. These announcements will always boost and rerate the SP, but without anything to support it, the SP will always just fizzle away like over the past year. The sheer number of great data announcements, acts like nails being hammered into the beams. Once BP sees what's being constructed, with the proof in front of them, then that's when they jump in.
Revenue in the short to medium term, I'm not suggesting product sales as that could be a few years away. I'm talking about any BP landing something like $300m in our laps to have the sole manufacturing rights, once studies have been completed and signed off by the FDA. A better partnership for mine would be handing over all of the IP and products for a licensing fee down the track. This allows the BP's to complete the studies before getting into manufacture, speeding things up ten fold. For a licensing purchase now IMU could receive something like $500m now with say 10-15% royalties on products over the next ten to twenty years.

When talking charts and shorters, I think that's mostly no longer relevant. The SP is reliant on fundamental news. Any volatility in the SP for mine is largely profit takers, or those who have run out of time with their investment. We saw a four year low just a week ago 3.4c its now traded at 4.4c - 27% higher. So why wouldn't there be some profit taking. This will be three steps forward and two steps back in SP, until significant data or a partnership deal lands over the next few months.

The good thing is, that its all happening !

-GO IMU!

Not Financial Advice - Opinions Only - DYOR!